Lifecore Biomedical, Inc. De annual gross margin
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2025
Lifecore Biomedical, Inc. De Gross Margin Growth & History (LFCR)
Lifecore Biomedical, Inc. De's gross margin was 31.37% for fiscal 2025.
View full Lifecore Biomedical, Inc. De company overviewLifecore Biomedical, Inc. De annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 · Dec 31 | 2025-12-31 | 31.37% | — |
| 2025 · May 25 | 2025-05-25 | 31.27% | −1.36 pp |
| 2024 | 2024-05-26 | 32.63% | +5.53 pp |
| 2023 | 2023-05-28 | 27.10% | −8.01 pp |
| 2022 | 2022-05-29 | 35.11% | −3.49 pp |
| 2021 | 2021-05-30 | 38.60% | +13.99 pp |
| 2020 | 2020-05-31 | 24.61% | +10.08 pp |
| 2019 | 2019-05-26 | 14.53% | −0.42 pp |
| 2018 | 2018-05-27 | 14.94% | −1.92 pp |
| 2017 | 2017-05-28 | 16.86% | +2.86 pp |
| 2016 | 2016-05-29 | 14.00% | +1.87 pp |
| 2015 | 2015-05-31 | 12.13% | −0.99 pp |
| 2014 | 2014-05-25 | 13.12% | −1.09 pp |
| 2013 | 2013-05-28 | 14.21% | −2.21 pp |
| 2012 | 2012-05-27 | 16.42% | −0.46 pp |
| 2011 | 2011-05-29 | 16.87% | +2.70 pp |
| 2010 | 2010-05-30 | 14.17% | — |
Lifecore Biomedical, Inc. De quarterly gross margin
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q2.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q3.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 35.34% | — |
| Q1 2026 | 2026-03-31 | 19.24% | — |
| Q3 2025 · Sep 30 | 2025-09-30 | 25.04% | — |
| Q4 2025 | 2025-05-25 | 38.37% | −7.22 pp |
| Q3 2025 · Feb 23 | 2025-02-23 | 28.01% | −5.31 pp |
| Q2 2025 | 2024-11-24 | 34.04% | +1.01 pp |
| Q1 2025 | 2024-08-25 | 21.81% | +10.68 pp |
| Q4 2024 | 2024-05-26 | 45.59% | +20.61 pp |
| Q3 2024 | 2024-02-25 | 33.31% | +1.10 pp |
| Q2 2024 | 2023-11-26 | 33.02% | +7.05 pp |
| Q1 2024 | 2023-08-27 | 11.12% | −14.08 pp |
| Q4 2023 | 2023-05-28 | 24.98% | −12.11 pp |
| Q3 2023 | 2023-02-26 | 32.21% | −0.82 pp |
| Q2 2023 | 2022-11-27 | 25.97% | −18.78 pp |
| Q1 2023 | 2022-08-28 | 25.20% | +0.37 pp |
| Q4 2022 | 2022-05-29 | 37.09% | +4.63 pp |
| Q3 2022 | 2022-02-27 | 33.04% | −6.27 pp |
| Q2 2022 | 2021-11-28 | 44.76% | −0.53 pp |
| Q1 2022 | 2021-08-29 | 24.83% | +1.48 pp |
| Q4 2021 | 2021-05-30 | 32.46% | +17.03 pp |
| Q3 2021 | 2021-02-28 | 39.31% | +26.20 pp |
| Q2 2021 | 2020-11-29 | 45.28% | +34.40 pp |
| Q1 2021 | 2020-08-30 | 23.35% | +12.29 pp |
| Q4 2020 | 2020-05-31 | 15.43% | −1.73 pp |
| Q3 2020 | 2020-02-23 | 13.11% | −0.76 pp |
| Q2 2020 | 2019-11-24 | 10.88% | −2.68 pp |
| Q1 2020 | 2019-08-25 | 11.06% | −2.05 pp |
| Q4 2019 | 2019-05-26 | 17.16% | −0.43 pp |
| Q3 2019 | 2019-02-24 | 13.87% | +0.20 pp |
| Q2 2019 | 2018-11-25 | 13.56% | +1.37 pp |
| Q1 2019 | 2018-08-26 | 13.10% | −3.13 pp |
| Q4 2018 | 2018-05-27 | 17.59% | +1.82 pp |
| Q3 2018 | 2018-02-25 | 13.67% | −4.02 pp |
| Q2 2018 | 2017-11-26 | 12.18% | −3.34 pp |
| Q1 2018 | 2017-08-27 | 16.24% | −2.21 pp |
| Q4 2017 | 2017-05-28 | 15.77% | −1.07 pp |
| Q3 2017 | 2017-02-26 | 17.69% | +7.74 pp |
| Q2 2017 | 2016-11-27 | 15.53% | +3.23 pp |
| Q1 2017 | 2016-08-28 | 18.45% | +5.16 pp |
| Q4 2016 | 2016-05-29 | 16.84% | +2.95 pp |
| Q3 2016 | 2016-02-28 | 9.95% | −2.24 pp |
| Q2 2016 | 2015-11-29 | 12.29% | +0.48 pp |
| Q1 2016 | 2015-08-30 | 13.28% | +2.66 pp |
| Q4 2015 | 2015-05-31 | 13.88% | +0.54 pp |
| Q3 2015 | 2015-03-01 | 12.19% | −3.76 pp |
| Q2 2015 | 2014-11-30 | 11.81% | +0.37 pp |
| Q1 2015 | 2014-08-31 | 10.62% | −0.83 pp |
| Q4 2014 | 2014-05-25 | 13.35% | +1.18 pp |
| Q3 2014 | 2014-02-23 | 15.95% | +1.09 pp |
| Q2 2014 | 2013-11-24 | 11.44% | −4.66 pp |
| Q1 2014 | 2013-08-25 | 11.45% | −2.04 pp |
| Q2 2013 · May 26 | 2013-05-26 | 12.16% | −5.64 pp |
| Q3 2013 | 2013-02-24 | 14.85% | −1.60 pp |
| Q2 2013 · Nov 25 | 2012-11-25 | 16.10% | +0.15 pp |
| Q1 2013 | 2012-08-26 | 13.48% | −1.86 pp |
| Q4 2012 | 2012-05-27 | 17.80% | +2.32 pp |
| Q3 2012 | 2012-02-26 | 16.45% | −0.52 pp |
| Q2 2012 | 2011-11-27 | 15.95% | −0.95 pp |
| Q1 2012 | 2011-08-28 | 15.35% | −2.85 pp |
| Q4 2011 | 2011-05-29 | 15.48% | — |
| Q3 2011 | 2011-02-27 | 16.97% | — |
| Q2 2011 | 2010-11-28 | 16.90% | — |
| Q1 2011 | 2010-08-29 | 18.19% | — |
Lifecore Biomedical, Inc. De gross margin trends
Between the periods ended 2010-05-30 and 2025-12-31, Lifecore Biomedical, Inc. De's gross margin increased from 14.17% to 31.37%, a change of +17.19 percentage points. The latest reported quarter, Q2 2026, shows 35.34%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lifecore Biomedical, Inc. De source filings ↗Community posts
Webster agrees Lifecore buyout with cash and contingent payments
Lifecore Biomedical ($LFCR) has agreed to be acquired by a Webster Equity Partners affiliate. Common shareholders would receive $6.28 in cash per share at closing, a 49.5% premium to the preceding trading day’s close, plus a non-tradable co ...
